Home ALS (Amyotrophic Lateral Sclerosis)
Cell Star

ALS (Amyotrophic Lateral Sclerosis)

Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects the motor neurons—nerve cells responsible for controlling voluntary muscles. As these neurons degenerate and die, the brain loses the ability to initiate and control muscle movement, leading to muscle weakness, paralysis, and eventually respiratory failure. ALS is a devastating disease that typically progresses rapidly and has a profound impact on the patient’s physica…

Types of ALS

There are two main types of ALS:

  • Sporadic ALS: The most common form, accounting for about 90–95% of cases. It occurs randomly without a known family history.
  • Familial ALS (FALS): Accounts for 5–10% of cases and is inherited through a mutated gene passed from one generation to the next.

Several gene mutations have been linked to familial ALS, including SOD1, TARDBP, FUS, and C9ORF72.

Causes and Risk Factors

The exact cause of ALS remains unknown, especially in sporadic cases. However, several risk factors and potential mechanisms have been proposed:

  • Genetic mutations in familial cases
  • Oxidative stress
  • Glutamate toxicity
  • Mitochondrial dysfunction
  • Abnormal protein aggregation
  • Immune system abnormalities
  • Environmental exposures, such as heavy metals, pesticides, or viral infections

The risk of ALS increases with age and is more common in men than women before age 65. Military veterans, particularly those deployed in the Gulf War, have been found to have a higher risk.

Symptoms

ALS symptoms typically begin gradually and vary from person to person. Early signs include:

  • Muscle twitching and cramps
  • Muscle weakness in the limbs, hands, or feet
  • Slurred speech and difficulty swallowing
  • Difficulty performing everyday activities (e.g., buttoning shirts or climbing stairs)

As the disease progresses:

  • Paralysis spreads to most voluntary muscles
  • Difficulty breathing due to diaphragm weakness
  • Inability to speak or eat independently
  • Emotional lability (uncontrolled laughing or crying)

Despite the severity of the disease, cognitive function is generally preserved in many patients, although some may experience frontotemporal dementia.

Diagnosis

Diagnosing ALS can be challenging, as there is no single definitive test. The diagnosis is typically made based on a combination of:

  • Clinical evaluation of muscle weakness, atrophy, and reflexes
  • Electromyography (EMG) to assess muscle electrical activity
  • Nerve conduction studies (NCS)
  • MRI scans to rule out other conditions
  • Blood and urine tests to exclude other diseases
  • Genetic testing for familial ALS

The El Escorial criteria are often used to support a diagnosis based on clinical and electrodiagnostic findings.

Disease Progression and Staging

ALS usually progresses rapidly. The average survival time after diagnosis is 2–5 years, though some patients live much longer (e.g., Stephen Hawking). The disease progression includes:

  • Early stage: Mild muscle weakness, especially in the hands or legs
  • Middle stage: More pronounced muscle wasting and difficulty speaking/swallowing
  • Late stage: Loss of mobility, dependence on ventilatory support, and near-total paralysis

Conventional Treatment and Management

FDA-approved medications:

  • Riluzole: Prolongs survival by reducing glutamate toxicity
  • Edaravone: Slows the decline of physical function in early-stage patients

Symptom management:.

  • Muscle relaxants (e.g., baclofen) for spasticity
  • Antidepressants for mood disturbances
  • Nutritional support via feeding tubes when swallowing is impaired
  • Non-invasive ventilation (BiPAP) to assist breathing

Multidisciplinary care:

  • A team of neurologists, physical therapists, respiratory therapists, speech therapists, and dietitians can greatly improve quality of life.

Stem Cell Therapy in ALS

Stem cell therapy is an evolving and promising approach for ALS, offering potential neuroprotective and regenerative effects.

Types of stem cells used:

  • Mesenchymal stem cells (MSCs)
  • Neural progenitor cells

Mechanisms:

  • Secretion of neurotrophic factors
  • Reduction of neuroinflammation
  • Support of motor neuron survival
  • Immunomodulation

Delivery methods:

  • Intravenous (IV)
  • Intrathecal (into the Cerebrospinal fluid)
  • Intracerebral (directly into the brain)

Clinical trials:

  • Studies have shown safety and potential efficacy

Hyperbaric Oxygen Therapy (HBOT) in ALS

HBOT is another supportive therapy under investigation for ALS. It involves inhaling pure oxygen in a pressurized chamber, increasing oxygen availability to damaged tissues.

Potential benefits:

  • Enhances cellular metabolism
  • Reduces inflammation and oxidative stress
  • Improves energy production in mitochondria

Limitations:

  • Requires frequent sessions to maintain potential benefits

Psychosocial Support

A diagnosis of ALS can be emotionally devastating for both the patient and their family. Psychological counseling, palliative care services, and support groups play a crucial role in helping patients cope.

End-of-Life Planning

As the disease progresses, discussions around end-of-life care become necessary. Advance directives, do-not-resuscitate (DNR) orders, and decisions regarding ventilator support should be discussed early and revisited regularly.

Lifestyle and Supportive Therapies

  • Nutrition: High-calorie, high-protein diets are often recommended due to increased energy expenditure and difficulty eating.
  • Physical therapy: Helps maintain muscle function and prevent contractures.
  • Speech therapy: Assists with communication and swallowing techniques.
  • Assistive technology: Eye-tracking devices, speech-generating systems, and powered wheelchairs enhance independence.

Conclusion

ALS is a severe and rapidly progressing neurodegenerative disorder with significant impacts on physical function and independence. While conventional treatment options are limited, advances in stem cell therapy and HBOT offer hope for improving symptoms and slowing disease progression. A multidisciplinary approach tailored to the individual’s needs remains the most effective strategy for managing ALS. Continued research into regenerative medicine and neuroprotection is essential to unlock better treatm…

Working Time
  • Monday-Saturday 09:00 AM  TO 06:00 PM
Contact Info